Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 37, Pages 13421-13426
Publisher
Proceedings of the National Academy of Sciences
Online
2014-09-03
DOI
10.1073/pnas.1402650111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
- (2013) M. Pourdehnad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction
- (2012) G Descamps et al. BRITISH JOURNAL OF CANCER
- Synthetic Silvestrol Analogues as Potent and Selective Protein Synthesis Inhibitors
- (2012) Tao Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A cellular response linking eIF4AI activity to eIF4AII transcription
- (2012) G. Galicia-Vazquez et al. RNA
- Emerging Therapeutics Targeting mRNA Translation
- (2012) A. Malina et al. Cold Spring Harbor Perspectives in Biology
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
- (2011) W-J Chng et al. LEUKEMIA
- The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma
- (2011) Joseph Gera et al. LEUKEMIA & LYMPHOMA
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
- (2011) N. Ilic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor
- (2010) B. Hoang et al. BLOOD
- Multiple Myeloma: Biology, Standard Therapy, and Transplant Therapy
- (2009) Morie A. Gertz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
- (2009) D. W. McMillin et al. CANCER RESEARCH
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
- (2008) J. R. Graff et al. CANCER RESEARCH
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
- (2008) C.-J. Lin et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started